Only a short term mindset would not expect an increase in shares. This happens with all small companies as the come close to approval and the company plans for success (e.g., marketing, sales force, GMP manufacturing).
It's necessary. They will wait till FDA-approval. At that moment they need very much money for many good chances. A new sales division, financing supply, financing debentures, expansion lab for some fases three, for example ADHD. First year still a loss, second year break even, third year earnings?? In the second or third year approval for ADHD??? And their are much more possibilities.